Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (460)
Cancellation by sponsor (239)
Cancellation or suspension (79)
Prescription medicine registration (45)
Cancellation for failure to pay annual charge (17)
Australian public assessment report (AusPar) (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2026 (6)
2025 (97)
2024 (73)
2023 (99)
2022 (70)
2021 (67)
2020 (112)
2019 (18)
2018 (68)
2017 (104)
2016 (27)
2015 (33)
2014 (13)
2013 (6)
2012 (4)
2011 (6)
2010 (16)
2009 (4)
2008 (3)
2007 (5)
2006 (2)
2005 (2)
2004 (2)
2003 (3)
2002 (2)
2001 (3)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Search

Sponsor content

850 result(s) found, displaying 171 to 180

CIPLA PAIN RELIEF PARACETAMOL + CODEINE 10, paracetamol 500mg + codeine phosphate hemihydrate 10mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
OMEGAPHARM IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vial Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
OMEGAPHARM IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
CIPLA PAIN RELIEF PARACETAMOL paracetamol 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
TIOVA tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack (393302)

1 September 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TIOVA tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack.
CIP TIOTROPIUM tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack (393295)

1 September 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIP TIOTROPIUM tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack.
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack (393303)

1 September 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack.
BLOOMS ESCITALOPRAM escitalopram (as oxalate) 20 mg film-coated tablet blister pack (407940)

31 July 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BLOOMS ESCITALOPRAM escitalopram (as oxalate) 20 mg film-coated tablet blister pack.
BLOOMS ESCITALOPRAM escitalopram (as oxalate) 10 mg film-coated tablet blister pack (407939)

31 July 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BLOOMS ESCITALOPRAM escitalopram (as oxalate) 10 mg film-coated tablet blister pack.
CIPFOSIN/ CIPLA FOSFOMYCIN (Cipla Australia Pty Ltd)

31 May 2024

Prescription medicine registration

Active ingredients: fosfomycin trometamol.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.